EuroPCR 2023 | Intravascular Lithotripsy (IVL) Balloon in the Treatment of Underexpanded Stents

Calcified coronary plaque (CCP) is a challenge for interventional cardiology. Stent underexpansion (SU) commonly associated with CCP could predispose to stent thrombosis or restenosis. Currently, SU in severe CCP can be treated by rotational atherectomy, orbital atherectomy, balloon cutting/scoring, non-compliant high-pressure balloons, or intravascular lithotripsy (IVL).

The aim of this meta-analysis was to determine the success rate of IVL treatment of SU in CCP. 

The primary endpoint was success rate of the IVL strategy, defined as adequate expansion of underexpanded stents. 

The analysis included 13 studies pooling 354 patients. Mean patient age was 71 years old, and most subjects were male. Follow-up was 2.6 months. The strategy was successful in 88.7% of cases. The mean minimal stent area (MSA) was reported in 6 studies; the pre-IVL value was 3.4 mm2 and the post-IVL value was 6.9 mm2.

Read also: EuroPCR 2023 | TAVR in Patients with Bicuspid Aortic Valve Stenosis.

The average stenosis diameter was reported in 7 studies, with a pre-IVL value of 69.4% and post-IVL value of 14.6%. The intraprocedural complication rate was 1.6%. 

Conclusion

Plaque modification with SU due to CCP with the use of IVL has proven to be safe, with a high success rate and very low incidence of complications.

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: Intravascular lithotripsy for the treatment of underexpanded stents: A meta-regression. 

Reference: Caminti et al. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Left Main Coronary Artery Disease: Intravascular Imaging-Guided PCI vs. Coronary Artery Bypass Grafting

Multiple randomized clinical trials have demonstrated superior outcomes with coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in patients with left main...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...